See also this year's filing and all EDGAR filings for this company.
PDF Report 0000944809_2022_OPKO_Health_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 2.063410593449693, 'aggregate_val': 1771457000, 'exp_sum': 578263000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 468857000, 'ResearchAndDevelopmentExpense': 76850000, 'remainder_Expenses': 32556000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.5876271971936236, 'aggregate_val': 1166950000, 'exp_sum': 450973000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 372672000, 'ResearchAndDevelopmentExpense': 73887000, 'remainder_Expenses': 4414000}} |
Graph
Absolute values for 0000944809, OPKO Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 823,013,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 842,284,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 734,418,000 |
| 4 | LiabilitiesCurrent | 330,008,000 |
| 5 | LiabilitiesNoncurrent | 384,581,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 533,708,819 |
| 9 | ResearchAndDevelopmentExpense | 78,486,118 |
| 10 | remainder_Expenses | 1,270,097,537 |
| 11 | remainder_Revenues | 1,937,863,496 |
| 12 | remainder_NetIncome | -25,950,928 |
| 13 | remainder_ComprehensiveNetIncome | -6,765,394 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,399,715,000 |
| 1 | Liabilities | 714,589,000 |
| 2 | Expenses | 1,882,292,474 |
| 3 | Revenues | 1,937,863,496 |
| 4 | StockholdersEquity | 1,685,126,000 |
| 5 | NetIncome | 29,620,094 |
| 6 | ComprehensiveNetIncome | 26,237,397 |
| 7 | BaseVar | 3,483,588,146 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.38 |
| 9 | EconomicCapitalRatio | 3.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
